Powder: -20°C for 3 years | In solvent: -80°C for 1 year
1. Ingenol ((-)-Ingenol) mebutate is an effective treatment for actinic keratosis. 2. Formulating novel derivatives from Ingenol esters may be an innovative approach to develop new lead compounds to reactivate latent HIV. 3. Ingenol is a weak PKC activator and possesses important anticancer activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 44.00 | |
5 mg | In stock | $ 96.00 | |
10 mg | In stock | $ 129.00 | |
25 mg | In stock | $ 259.00 | |
50 mg | In stock | $ 492.00 | |
100 mg | In stock | $ 673.00 | |
500 mg | In stock | $ 1,430.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 97.00 |
Description | 1. Ingenol ((-)-Ingenol) mebutate is an effective treatment for actinic keratosis. 2. Formulating novel derivatives from Ingenol esters may be an innovative approach to develop new lead compounds to reactivate latent HIV. 3. Ingenol is a weak PKC activator and possesses important anticancer activity. |
Targets&IC50 | PKC:30 μM(Ki) |
Source |
Synonyms | (-)-Ingenol |
Molecular Weight | 348.43 |
Formula | C20H28O5 |
CAS No. | 30220-46-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (143.5 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ingenol 30220-46-3 Chromatin/Epigenetic Cytoskeletal Signaling PKC inhibit Protein kinase C (-)-Ingenol Inhibitor inhibitor